• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BeautyHealth Names Michael Monahan Chief Financial Officer

    8/9/23 7:25:00 AM ET
    $SKIN
    $CSPR
    Medical/Dental Instruments
    Health Care
    Diversified Commercial Services
    Miscellaneous
    Get the next $SKIN alert in real time by email

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announces Michael Monahan has been named Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230809857384/en/

    Michael Monahan, BeautyHealth (Photo: Business Wire)

    Michael Monahan, BeautyHealth (Photo: Business Wire)

    "Michael joins BeautyHealth as we bring to life our vision of a multi-brand ecosystem company, with a significant and untapped runway ahead. He is a highly regarded CFO with a strong blend of financial expertise and strategic vision who will continue to enhance our financial strategy, planning and reporting capabilities. I am looking forward to welcoming Michael to BeautyHealth's management team," said BeautyHealth President and CEO Andrew Stanleick.

    With nearly 15 years of experience as a public and private company CFO and more than 25 years of accounting and financial management experience, Monahan has a track record of driving financial and operational success in high-growth businesses. Most recently, he served as CFO of Casper Sleep (NYSE:CSPR), following its IPO. Prior, he served as CFO of Nutrisystem (NASDAQ:NTRI), quintupling its market cap and overseeing key M&A during his tenure.

    "BeautyHealth is an impressive category-creating company with a strong foundation and a lot of room for profitable growth," said Monahan. "I am delighted to partner with Andrew and the team to continue to build the business as a true multi-brand ecosystem."

    Commenting on Woo's departure, Stanleick said, "The Board and I are grateful for Liyuan's many meaningful contributions over the past several years. She has been a dynamic force during this transformative period for BeautyHealth, which included our journey to becoming a public company. We wish Liyuan every success in her future endeavors."

    About The Beauty Health Company

    The Beauty Health Company (NASDAQ:SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types in more than 90 countries. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/, and learn more at beautyhealth.com or LinkedIn.

    Forward-Looking Statements

    Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding The Beauty Health Company's strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

    These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside The Beauty Health Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

    Important factors that may affect actual results or outcomes include, among others: The Beauty Health Company's ability to manage growth; The Beauty Health Company's ability to execute its business plan; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; and the possibility that The Beauty Health Company may be adversely affected by other economic, business, and/or competitive factors. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230809857384/en/

    Get the next $SKIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SKIN
    $CSPR

    CompanyDatePrice TargetRatingAnalyst
    SkinHealth Systems Inc.
    $SKIN
    9/19/2025$3.50Buy
    Roth Capital
    SkinHealth Systems Inc.
    $SKIN
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    SkinHealth Systems Inc.
    $SKIN
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    SkinHealth Systems Inc.
    $SKIN
    11/14/2023Neutral → Underweight
    JP Morgan
    SkinHealth Systems Inc.
    $SKIN
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    SkinHealth Systems Inc.
    $SKIN
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    SkinHealth Systems Inc.
    $SKIN
    11/14/2023Buy → Hold
    The Benchmark Company
    SkinHealth Systems Inc.
    $SKIN
    11/14/2023Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $SKIN
    $CSPR
    SEC Filings

    View All

    Amendment: SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - SkinHealth Systems Inc. (0001818093) (Filer)

    5/21/26 4:40:52 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - SkinHealth Systems Inc. (0001818093) (Filer)

    5/12/26 4:08:38 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by SkinHealth Systems Inc.

    10-Q - SkinHealth Systems Inc. (0001818093) (Filer)

    5/7/26 5:16:36 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Beattie Edward Scott

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:24:15 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Shridharani Sachin Mahavir

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:19:24 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Tripp Kenneth Robert

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:15:55 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/13/24 5:00:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health

    LONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering. HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial's proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for

    6/2/26 8:05:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems Reports First Quarter 2026 Financial Results

    LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut

    5/7/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

    LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa

    4/29/26 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on The Beauty Health Company with a new price target

    Roth Capital initiated coverage of The Beauty Health Company with a rating of Buy and set a new price target of $3.50

    9/19/25 8:39:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Jefferies with a new price target

    Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

    11/15/23 7:13:27 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Financials

    Live finance-specific insights

    View All

    SkinHealth Systems Reports First Quarter 2026 Financial Results

    LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut

    5/7/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

    LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa

    4/29/26 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results

    LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 ("Q4 2025"). "Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold," said Pedro Malha, President and CEO of BeautyHealth. "BeautyHealth enters 2026 with a strong foundation — a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus no

    3/12/26 4:01:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Leadership Updates

    Live Leadership Updates

    View All

    SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

    LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors to its Board of Directors (the "Board"): Mr. Kenneth Tripp, Dr. Sachin Shridharani, and Mr. E. Scott Beattie, each effective as of April 17, 2026. "These three appointments reflect exactly the kind of Board we are building at SkinHealth Systems – one that brings extensive operational expertise in medtech, deep clinical authority in aesthetics, and proven leadership in scaling iconic global consumer brands," said Brent Saunders, Chairman of SkinHealth Systems

    4/22/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

    LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré

    11/3/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    $CSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care